MIT's Single-Dose HIV Vaccine Breakthrough Offers New Hope
Researchers at MIT and Scripps have developed a promising HIV vaccine approach using two adjuvants that elicit a strong, diverse immune response with just one dose, potentially revolutionizing vaccine strategies for HIV and other infectious diseases.